Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson’s disease and sleep disorders: a randomized, double-blind trial

被引：0
|
作者：
Fatemeh Hadi
Elmira Agah
Samaneh Tavanbakhsh
Zahra Mirsepassi
Seyed Vahid Mousavi
Negin Talachi
Abbas Tafakhori
Vajiheh Aghamollaii
机构：
[1] Islamic Azad University,Department of Clinical Pharmacy, Pharmaceutical Sciences Branch
[2] Iranian Center of Neurological Research,Students’ Scientific Research Center
[3] Neuroscience Institute,NeuroImmunology Research Association (NIRA)
[4] Tehran University of Medical Sciences,Department of Neurology
[5] Tehran University of Medical Sciences,Department of Psychiatry
[6] Universal Scientific Education and Research Network (USERN),undefined
[7] Roozbeh Psychiatric Hospital,undefined
[8] Tehran University of Medical Sciences,undefined
[9] Tehran University of Medical Sciences,undefined
来源：
Neurological Sciences | 2022年 / 43卷
关键词：
Parkinson’s disease; Clinical trial; Sleep; Trazodone; Clonazepam; Melatonin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6141 / 6148
页数：7
相关论文
共 50 条
  • [21] Effects of Unilateral Stimulation in Parkinson's Disease: A Randomized Double-Blind Crossover Trial
    Zeng, Zhitong
    Wang, Linbin
    Shi, Weikun
    Xu, Lu
    Lin, Zhengyu
    Xu, Xinmeng
    Huang, Peng
    Pan, Yixin
    Chen, Zhonglue
    Ling, Yun
    Ren, Kang
    Zhang, Chencheng
    Sun, Bomin
    Li, Dianyou
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [22] Trazodone Improves Sleep Parameters in Alzheimer Disease Patients: A Randomized, Double-Blind, and Placebo-Controlled Study
    Camargos, Einstein F.
    Louzada, Luciana L.
    Quintas, Juliana L.
    Naves, Janeth O. S.
    Louzada, Fernando M.
    Nobrega, Otavio T.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 22 (12): : 1565 - 1574
  • [23] Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial
    Kakhaki, Reza Daneshvar
    Ostadmohammadi, Vahidreza
    Kouchaki, Ebrahim
    Aghadavod, Esmat
    Bahmani, Fereshteh
    Tamtaji, Omid Reza
    Reiter, Russel J.
    Mansournia, Mohammad Ali
    Asemi, Zatollah
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 195
  • [24] Efficacy and safety of SQJZ herbal mixtures on nonmotor symptoms in Parkinson disease patients Protocol for a randomized, double-blind, placebo-controlled trial
    Shi, Jing
    Tian, Jinzhou
    Li, Ting
    Qin, Bin
    Fan, Dongsheng
    Ni, Jingnian
    Wei, Mingqing
    Zhang, Xuekai
    Liu, Na
    Liu, Jianping
    Li, Yumeng
    Liu, Weiwei
    Wang, Yongyan
    MEDICINE, 2017, 96 (50)
  • [25] Glycopyrrolate for sialorrhea in Parkinson disease A randomized, double-blind, crossover trial
    Arbouw, M. E. L.
    Movig, K. L. L.
    Koopmann, M.
    Poels, P. J. E.
    Guchelaar, H. -J.
    Egberts, T. C. G.
    Neef, C.
    van Vugt, J. P. P.
    NEUROLOGY, 2010, 74 (15) : 1203 - 1207
  • [26] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy and Safety
    Olanow, C. W.
    Antonini, A.
    Kieburtz, K.
    Fernandez, H. H.
    Espay, A. J.
    Standaert, D. G.
    Vanagunas, A.
    Widnell, K. L.
    Freeman, S.
    Robieson, W. Z.
    Pritchett, Y.
    Chatamra, K.
    Benesh, J.
    Lenz, R. A.
    ANNALS OF NEUROLOGY, 2012, 72 : S102 - S102
  • [27] Melatonin Fails to Improve Sleep or Agitation in Double-Blind Randomized Placebo-Controlled Trial of Institutionalized Patients With Alzheimer Disease
    Gehrman, Philip R.
    Connor, Donald J.
    Martin, Jennifer L.
    Shochat, Tamar
    Corey-Bloom, Jody
    Ancoli-Israel, Sonia
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (02): : 166 - 169
  • [28] Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
    Howard E. Gendelman
    Yuning Zhang
    Pamela Santamaria
    Katherine E. Olson
    Charles R. Schutt
    Danish Bhatti
    Bhagya Laxmi Dyavar Shetty
    Yaman Lu
    Katherine A. Estes
    David G. Standaert
    Elizabeth Heinrichs-Graham
    LuAnn Larson
    Jane L. Meza
    Matthew Follett
    Erica Forsberg
    Gary Siuzdak
    Tony W. Wilson
    Carolyn Peterson
    R. Lee Mosley
    npj Parkinson's Disease, 3
  • [29] NR-SAFE: A Randomized, Double-blind Safety Trial of High Dose Nicotinamide Riboside in Parkinson's Disease
    Berven, H.
    Kverneng, S.
    Sheard, E.
    Sognen, M.
    Geijerstam, S.
    Haugarvoll, K.
    Skeie, G. O.
    Dolle, C.
    Tzoulis, C.
    MOVEMENT DISORDERS, 2023, 38 : S12 - S12
  • [30] NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease
    Berven H.
    Kverneng S.
    Sheard E.
    Søgnen M.
    Af Geijerstam S.A.
    Haugarvoll K.
    Skeie G.-O.
    Dölle C.
    Tzoulis C.
    Nature Communications, 14 (1)
12345